WordNet
- be a contributing factor; "make things factor into a companys profitability"
- any of the numbers (or symbols) that form a product when multiplied together
- an independent variable in statistics
- anything that contributes causally to a result; "a number of factors determined the outcome"
- consider as relevant when making a decision; "You must factor in the recent developments" (同)factor in, factor out
- resolve into factors; "a quantum computer can factor the number 15" (同)factor in, factor out
- an event known to have happened or something known to have existed; "your fears have no basis in fact"; "how much of the story is fact and how much fiction is hard to tell"
- a concept whose truth can be proved; "scientific hypotheses are not facts"
- a piece of information about circumstances that exist or events that have occurred; "first you must collect all the facts of the case"
- a statement or assertion of verified information about something that is the case or has happened; "he supported his argument with an impressive array of facts"
PrepTutorEJDIC
- (…の)『要因』,(…を生み出す)要素《+『in』+『名』(do『ing』)》 / 囲数,約数 / 代理人,《おもに英》仲買人 / =factorize
- 〈C〉『事実』,実際にある(あった)事 / 〈U〉真相,真実(truth) / 《the~》(法律用語で)犯行
- 凝固,凝結
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 後天性の凝固因子阻害物質 acquired inhibitors of coagulation
- 2. 稀な（劣性遺伝性）凝固異常 rare recessively inherited coagulation disorders
- 3. 肝臓の合成能の検査（アルブミン、凝固因子、プロトロンビン時間など） tests of the livers biosynthetic capacity eg albumin coagulation factors prothrombin time
- 4. 血漿分画製剤および組換えDNA産生凝固因子 plasma derivatives and recombinant dna produced coagulation factors
- 5. 止血の概要 overview of hemostasis
English Journal
- Autoantibodies to coagulation factors: From pathophysiology to diagnosis and therapy.
- Cugno M, Gualtierotti R, Tedeschi A, Meroni PL.SourceMedicina Interna, Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy. Electronic address: massimo.cugno@unimi.it.
- Autoimmunity reviews.Autoimmun Rev.2014 Jan;13(1):40-8. doi: 10.1016/j.autrev.2013.08.001. Epub 2013 Aug 14.
- Autoantibodies may develop against coagulation factors altering their function or promoting their rapid clearance. In non-congenitally deficient patients, they are usually in association with autoimmune diseases, malignancies, pregnancy or advanced age. The possible development of coagulation factor
- PMID 23954454
- Surgical interventions in childhood rare factor deficiencies: a single-center experience from Turkey.
- Salcioglu Z, Tugcu D, Akcay A, Sen HS, Aydogan G, Akici F, Demirkaya M, Ayaz NA, Sander S, Tireli GA, Baslar Z.SourceaKanuni Sultan Süleyman Education and Research Hospital, Pediatric Hematology and Oncology Clinic bKanuni Sultan Süleyman Education and Research Hospital, Pediatric Surgery Clinic cIstanbul University, Cerrahpasa Medical School, Internal Medicine Department, Istanbul, Turkey.
- Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.Blood Coagul Fibrinolysis.2013 Dec;24(8):854-61. doi: 10.1097/MBC.0b013e3283655667.
- Congenital rare factor deficiencies may present in infancy by life-threatening bleedings or may not show any symptoms until adulthood. It is reported more commonly in countries having consanguineous marriages. Data regarding surgical interventions of rare congenital factor deficiencies are based on
- PMID 24158119
- Synthesis and characterization of novel fluorogenic substrates of coagulation factor XIII-A.
- Hardes K, Zouhir Hammamy M, Steinmetzer T.SourceInstitute of Pharmaceutical Chemistry, Philipps University Marburg, D-35032 Marburg, Germany.
- Analytical biochemistry.Anal Biochem.2013 Nov 15;442(2):223-30. doi: 10.1016/j.ab.2013.07.043. Epub 2013 Aug 9.
- Further development of our recently published Glu(pNA)-containing peptides (Anal. Biochem. 428 (2012) 73-80) provided new fluorogenic substrates for the activated blood coagulation factor XIII. A first series was designed by incorporation of Glu(AMC) at the penultimate position from the N terminus.
- PMID 23933241
Japanese Journal
- 左大腿内側筋内血腫から発症し後天性第13因子欠乏症であることが判明した1例
- 森本 大樹,小川 剛,山本 浩司
- 中部日本整形外科災害外科学会雑誌. 中部日本整形外科災害外科学会抄録 54(2), 251-252, 2011-03-01
- NAID 10029071660
- その他の先天性凝固因子欠損症の診断と治療
- 長江 千愛,瀧 正志
- 日本血栓止血学会誌 = The Journal of Japanese Society on Thrombosis and Hemostasis 21(3), 297-300, 2010-06-01
- … 血友病類縁疾患は凝固因子抗原量と活性の関係から，Type 1（凝固因子欠乏症）と，Type 2（凝固因子異常症）の二つに分類される．(2) わが国における血友病類縁疾患は先天性フィブリノゲン欠乏症と第XIII因子欠乏症，第VII因子欠乏症が多い．(3) 血友病類縁疾患の診断は，病歴や家族歴，出血症状や部位，凝固スクリーニング検査と各種凝固因子の定量や活性値を測定して行う．(4) 血友病類縁疾患の臨床症状は欠 …
- NAID 10026400440
Related Pictures
★リンクテーブル★
| リンク元 | 「凝固第XIII因子」 |
| 拡張検索 | 「blood coagulation factor XIII」 |
| 関連記事 | 「fact」「factor」「factor XIII」「coagulation factor」 |
「凝固第XIII因子」
「blood coagulation factor XIII」
「fact」
- n.
「factor」
- n.
「factor XIII」
[★] 第XIII因子。フィブリン安定化因子 fibrin stabilizing factor